IP Library › Assignment 040217/0288
Patent Assignment
Reel/Frame 040217/0288

Assignment of Assignor's Interest

Recorded: 2016-11-03 Pages: 2
Assignor
RESVERLOGIX CORP.
Executed: 2013-03-01
Assignee
RVX THERAPEUTICS INC.
202,279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Biaryl Derivatives as Bromodomain Inhibitors
Patent: 9,765,039 →
Application: 14/085,544 →
Publication: US 2014/0140956
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement Jul 14, 2014
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 033312/0422 →
Assignment of Assignor's Interest Nov 3, 2016
From: FAIRFAX, DAVID JOHN; QUINN, JOHN FREDERICK; WAGNER, GREGORY STEVEN; MARTIN, GREGORY SCOTT
To: RESVERLOGIX CORP.
Reel/Frame 040561/0873 →
Change of Name Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →